Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical validity of NGS and innovation in clinical diagnosis

Dr Jeffrey Ross - Albany Medical College, Albany, USA

Clinical validity of NGS and innovation in clinical diagnosis ( Dr Jeffrey Ross - Albany Medical College, Albany, USA )

Expert insight: Metastatic hormone sensitive prostate cancer latest

Professor Karim Fizazi and Professor Nicholas James

Expert insight: Metastatic hormone sensitive prostate cancer latest ( Professor Karim Fizazi and Professor Nicholas James )

Focus on non-metastatic castration resistant prostate cancer

Professor Noel Clarke and Dr Eric Small

Focus on non-metastatic castration resistant prostate cancer ( Professor Noel Clarke and Dr Eric Small )

Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial...

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA

Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )

Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma

Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada

Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma ( Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada )

Genetic mutations: New therapeutic avenues in metastatic prostate cancer

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Genetic mutations: New therapeutic avenues in metastatic prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

6-factor prognostic model for patients with advanced urothelial carcinoma

Dr Gregory Pond - McMaster University, Hamilton, Ontario

6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )

Comment: Urothelial cancer research from ASCO GU 2018

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA

Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and...

Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )

Genomic profiling of muscle invasive bladder cancer to predict response to...

Dr David Miyamoto - Massachusetts General Hospital, Boston, USA

Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy ( Dr David Miyamoto - Massachusetts General Hospital, Boston, USA )

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in...

Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA

$Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )$

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )

More from ecancer